News

Ferguson has announced the launch of the Ferguson OTC (over-the-counter) Center of Excellence, a new initiative designed to address the rapid increase of promotion and use of OTC

BioDelivery Sciences announced the consolidation of the company’s laboratory and other operations in Newark, New Jersey to the company’s headquarters in Raleigh, North Carolina. BDSI will vacate its

PTC Therapeutics (PTC) has entered into an exclusive research collaboration and licensing agreement with Roche for the development of orally bioavailable small molecules utilizing PTC’s technology called Gene

Santhera has initiated the pivotal phase III study with Catena/Sovrima for the treatment of Duchenne Muscular Dystrophy. Reportedly, the 12-month study will enroll up to 240 patients in

Acceleron Pharma has reported the preliminary results from the ACE-031 phase 1 single dose clinical trial indicating that ACE-031 was safe and well-tolerated at all dose levels and

Molecular Insight has entered into an agreement to sub-license its Onalta brand 90-Y edotreotide radiotherapeutic in certain countries in Europe, the Middle East, North Africa, Russia and Turkey

Knopp Neurosciences (Knopp) has received Fast Track designation from the FDA for the development of KNS-760704 in amyotrophic lateral sclerosis (ALS). Knopp has completed the randomized, placebo-controlled portion

Accumetrics has signed a new exclusive agreement with Grifols for the distribution of its VerifyNow in Spain, Portugal and Chile. The VerifyNow assesses response to life-saving antiplatelet therapies,

The Medicines Company has reported that the US Patent and Trademark Office (PTO) issued a new US patent No 7582727 (‘727 patent). The ‘727 patent relates to a